PIPERAFIZINES
A AND B, POTENTIATORS OF CYTOTOXICITY OF VINCRISTINE Hideo Kamei, Masahisa Oka, Yasutaro Hamagishi, Koji Tomita, Masataka Konishi and Toshikazu Oki Bristol-Myers Research Institute, Ltd., Tokyo Research Center, 2-9-3 Shimo-meguro, Meguro-ku, Tokyo 153, Japan (Received for publication January 18, 1990) Wehave recently discovered a complex of new isotetracenone group antibiotics, rubiginones, in our screening for vincristine (VCR)-induced cytotoxicity potentiators1*. In the continuation of the screening program, an actinomycete strain Q576-2 identified as Streptoverticillium aspergilloides, was found to produce a new active substance. Isolation and chemical studies of the responsible substance designated piperafizine showed that it was a complex of two components A and B structurally classified in the diketopiperazine family. This note presents a brief discussion of the producing organism, production, isolation, chemical properties and biological activities of piperafizines A and B. Strain Q576-2 was isolated from a soil sample collected in the Fiji Islands. The aerial mycelia bore tufted short straight spore-chains on a biverticillate sporophore. The spores were oblong (0.6 by 1.0 to 2.5^m) with a smooth surface. The color of aerial myceliumwas white at first and later turned to light gray or light yellow. The strain grew between 16°C and 41°C and did not produce melanoid, prodigiosin or other diagnostic pigments. The following tests were positive: Tolerance to 7%NaCl; production AUG. 1990 of gelatinase, amylase and nitrate reductase; utilization of D-fructose, myo-inosito\ and dmannitol. Negative responses were: Production of tyrosinase; utilization of L-arabinose, D-xylose, L-rhamnose, sucrose and raffinose. The whole-cell hydrolysate contained LL-diaminopimelic acid; the phospholipids had phosphatidylethanolamine indicating that the strain belonged to type I cell wall and type P-II phospholipid. Based on the above results, strain Q576-2 was identified as S. aspergilloides2~*\ Piperafizine was produced by shake flask or tank fermentation using a mediumcomposedof soluble starch 2%, soybean meal 1%, NaCl 2% and CaCO3 0.5%. In a tank fermenter (200 liters), fermentation was carried out at 28°C with agitation of 250rpm and aeration of 120 liters/minute; 8^g/ml of activity was obtained after 90 hours. The culture broth (220 liters) was extracted with BuOH(100 liters) and the extract was concentrated to an aqueous solution which was extracted with dichloromethane. After concentration, the active principle was purified by Table 1 . The data of piperafizine B were nearly identical with those of 3Z,6Z-dibenzylidene-2, 5-dioxopiperazine5 '6) and identity was confirmed by a direct comparison with an authentic synthetic sample7). Piperafizine A showed molecular weight of 304, 14 mass units (a closely related physico-chemical and spectral properties. The methyl group was deduced to be on a nitrogen atom rather than on an oxygen atom based on its chemical shifts in the NMR(<5H 2.83 and Sc 36.8). In fact, piperafizine A was distinctly different from neihumicin, a cytotoxic antibiotic with 3Z,6Z-dibenzylidene-2-methoxy-3,6-dihydropyrazin-5-one structure by direct comparison8).
Upon catalytic hydrogenation, piperafizine A yielded a complex of two tetrahydro derivatives (stereoisomers) which was hydrolyzed with 6 n HC1 to afford phenylalanine and N-methylphenylalanine. When treated with dimethyl sulfate, both piperafizines A and B produced an identical di-TV-methyl derivative. Thus 3Z,6Z-dibenzylidene-l -methyl-2, 5-dioxopiperazine was assigned to piperafizine A (Fig.   1 ). Although a synthesis of this molecule was recently reported9), this is the first isolation from a natural source. spectively, practically non-cytotoxic concentrations of 2 and lO^g/ml were used for potentiation tests of piperafizines A and B, respectively. Piperafizine A markedly enhanced the cytotoxicity of VCR against Moser cells and moderately against the VCR-sensitive and VCR-resistant P388, while piperafizine B showed a slight potentiation effect only against the VCR-resistant P388 cells. The di-iV-methyl derivative synthesized from the natural componentsalso exhibited slight potentiation effect. Although their activity was considerably lower than that of verapamil tested as a reference, piperafizines significantly increased the accumulation of vincristine in both Moser and P388/VCR cells in our preliminary experiments. In leukemia-bearing mice, piperafizine A significantly increased life span when used in combination with VCR.
